Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) EPS (Basic): 2023-2024

Historic EPS (Basic) for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to -$5.81.

  • Artiva Biotherapeutics' EPS (Basic) rose 109.07% to $1.35 in Q4 2024 from the same period last year, while for Dec 2024 it was -$38.81, marking a year-over-year change of. This contributed to the annual value of -$5.81 for FY2024, which is 83.76% up from last year.
  • Latest data reveals that Artiva Biotherapeutics reported EPS (Basic) of -$5.81 as of FY2024, which was up 83.76% from -$35.78 recorded in FY2023.
  • In the past 5 years, Artiva Biotherapeutics' EPS (Basic) ranged from a high of -$5.81 in FY2024 and a low of -$35.78 during FY2023.
  • Its 2-year average for EPS (Basic) is -$20.80, with a median of -$20.80 in 2023.
  • Data for Artiva Biotherapeutics' EPS (Basic) shows a peak YoY surged of 83.76% (in 2024) over the last 5 years.
  • Artiva Biotherapeutics' EPS (Basic) (Yearly) stood at -$35.78 in 2023, then spiked by 83.76% to -$5.81 in 2024.